Has Jacob Mathew, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,344 in general payments to Jacob Mathew, MD across 54 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jacob Mathew, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jacob Mathew, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jacob Mathew, MD

Neurology · Port Jefferson, NYNPI 1407857634

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by UCB, Inc. at 39.2% of the total. Reporting peaked in 2021 at $437 and has fallen 50.7% since, to $216 in 2025. That places this record below the midpoint for neurology clinicians in NY, where the typical reported total is $913.

$1,344in general payments, 2019–2025

Across 54 payments — averaging $24.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB, Inc.$527
Eisai Inc.$127
Johnson & Johnson$123
Teva Pharmaceuticals USA, Inc.$119
AbbVie$114
Neurocrine Biosciences, Inc.$86
plus $249 from 8 others

What the payments were for

Food & beverage$1,344100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB, Inc.	23	$527
Eisai Inc.	4	$127
Johnson & Johnson	1	$123
Teva Pharmaceuticals USA, Inc.	5	$119
AbbVie(2 entities)	6	$114
Neurocrine Biosciences, Inc.	3	$86
Biohaven Pharmaceuticals, Inc.	3	$80
Axsome Therapeutics, Inc.	2	$42
Supernus Pharmaceuticals, Inc.	2	$38
Pfizer	1	$23
Novo Nordisk	1	$19
Alfasigma USA, Inc.	1	$19
Biogen	1	$18
Bardy Diagnostics, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XARELTO$123

How this compares

$1,344 in reported general payments places this provider in the 50th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$106,785

Medicare patients

261

Services billed

780

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	138	$12,881
Divalproex Sodium	72	$10,444
Lacosamide	41	$4,417
Lidocaine	20	$2,675
Levetiracetam	40	$2,570
Carbamazepine	36	$2,089
Memantine Hcl	81	$1,760
Carbidopa-LevodopaCarbidopa/Levodopa	103	$1,083
Levetiracetam ErLevetiracetam	21	$1,075
Divalproex Sodium ErDivalproex Sodium	23	$1,040
Gabapentin	177	$1,004
Clobazam	12	$988
Lamotrigine	11	$870
Primidone	41	$568
Niacin ErNiacin	21	$513

Paid to pharmacies, not to this prescriber.

Other neurology in Port Jefferson

Idan SharonBrooklyn$2.1M
Allan PerelStaten Island$1.7M
Nicolas SaikaliAmherst$1.5M
David KreitzmanCommack$1.5M
Charles ArgoffAlbany$1.2M
Stephen KriegerNew York$1.1M
Robert FeketeHawthorne$1M
Jennifer McVigeAmherst$982K
Warren SpinnerPort Jefferson Station$791K
Richard LiptonBronx$753K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →